The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Genomic and Proteomic Tool-Global Market Insights and Sales Trends 2024
Synopsis
Smart food logistics provider helps FMCG industries to maintain the quality of foods, such as fruits and vegetables, so that it does not spoil. Smart food logistics companies use wireless temperature sensors that help preserve frozen foods and provide multi-zone monitoring in refrigerated trucks and trailers.
The global Genomic and Proteomic Tool market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Genomic and Proteomic Tool in various end use industries. The expanding demands from the Research Labs and Institutes, Drug Discovery, Bioinformatics and Others, are propelling Genomic and Proteomic Tool market. Genomics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Proteomics segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Genomic and Proteomic Tool market, driven by demand from China, the second largest economy with some signs of stabilising, the Genomic and Proteomic Tool market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genomic and Proteomic Tool, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Genomic and Proteomic Tool market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genomic and Proteomic Tool market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genomic and Proteomic Tool sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genomic and Proteomic Tool covered in this report include 3billion, Inc., Bio-Rad Laboratories, Inc., Lucigen Corp., Macrogen, Inc., Abbott, Thermal Fisher Scientific, Inc., Bio-Synthesis, Inc., GE Healthcare and QIAGEN NV, etc.
The global Genomic and Proteomic Tool market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
3billion, Inc.
Bio-Rad Laboratories, Inc.
Lucigen Corp.
Macrogen, Inc.
Abbott
Thermal Fisher Scientific, Inc.
Bio-Synthesis, Inc.
GE Healthcare
QIAGEN NV
Novogene Corp.
Waters Corp.
OriGene Technologies
Takara Bio, Inc.
Vela Diagnostics
Global Genomic and Proteomic Tool market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genomic and Proteomic Tool market, Segment by Type:
Genomics
Proteomics
Global Genomic and Proteomic Tool market, by Application
Research Labs and Institutes
Drug Discovery
Bioinformatics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Genomic and Proteomic Tool companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Smart food logistics provider helps FMCG industries to maintain the quality of foods, such as fruits and vegetables, so that it does not spoil. Smart food logistics companies use wireless temperature sensors that help preserve frozen foods and provide multi-zone monitoring in refrigerated trucks and trailers.
The global Genomic and Proteomic Tool market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Genomic and Proteomic Tool in various end use industries. The expanding demands from the Research Labs and Institutes, Drug Discovery, Bioinformatics and Others, are propelling Genomic and Proteomic Tool market. Genomics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Proteomics segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Genomic and Proteomic Tool market, driven by demand from China, the second largest economy with some signs of stabilising, the Genomic and Proteomic Tool market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genomic and Proteomic Tool, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Genomic and Proteomic Tool market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genomic and Proteomic Tool market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genomic and Proteomic Tool sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genomic and Proteomic Tool covered in this report include 3billion, Inc., Bio-Rad Laboratories, Inc., Lucigen Corp., Macrogen, Inc., Abbott, Thermal Fisher Scientific, Inc., Bio-Synthesis, Inc., GE Healthcare and QIAGEN NV, etc.
The global Genomic and Proteomic Tool market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
3billion, Inc.
Bio-Rad Laboratories, Inc.
Lucigen Corp.
Macrogen, Inc.
Abbott
Thermal Fisher Scientific, Inc.
Bio-Synthesis, Inc.
GE Healthcare
QIAGEN NV
Novogene Corp.
Waters Corp.
OriGene Technologies
Takara Bio, Inc.
Vela Diagnostics
Global Genomic and Proteomic Tool market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genomic and Proteomic Tool market, Segment by Type:
Genomics
Proteomics
Global Genomic and Proteomic Tool market, by Application
Research Labs and Institutes
Drug Discovery
Bioinformatics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Genomic and Proteomic Tool companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Genomic and Proteomic Tool
1.1 Genomic and Proteomic Tool Market Overview
1.1.1 Genomic and Proteomic Tool Product Scope
1.1.2 Genomic and Proteomic Tool Market Status and Outlook
1.2 Global Genomic and Proteomic Tool Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Genomic and Proteomic Tool Market Size by Region (2018-2029)
1.4 Global Genomic and Proteomic Tool Historic Market Size by Region (2018-2023)
1.5 Global Genomic and Proteomic Tool Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Genomic and Proteomic Tool Market Size (2018-2029)
1.6.1 North America Genomic and Proteomic Tool Market Size (2018-2029)
1.6.2 Europe Genomic and Proteomic Tool Market Size (2018-2029)
1.6.3 Asia-Pacific Genomic and Proteomic Tool Market Size (2018-2029)
1.6.4 Latin America Genomic and Proteomic Tool Market Size (2018-2029)
1.6.5 Middle East & Africa Genomic and Proteomic Tool Market Size (2018-2029)
2 Genomic and Proteomic Tool Market by Type
2.1 Introduction
2.1.1 Genomics
2.1.2 Proteomics
2.2 Global Genomic and Proteomic Tool Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Genomic and Proteomic Tool Historic Market Size by Type (2018-2023)
2.2.2 Global Genomic and Proteomic Tool Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Genomic and Proteomic Tool Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Genomic and Proteomic Tool Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Genomic and Proteomic Tool Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Genomic and Proteomic Tool Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Genomic and Proteomic Tool Revenue Breakdown by Type (2018-2029)
3 Genomic and Proteomic Tool Market Overview by Application
3.1 Introduction
3.1.1 Research Labs and Institutes
3.1.2 Drug Discovery
3.1.3 Bioinformatics
3.1.4 Others
3.2 Global Genomic and Proteomic Tool Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Genomic and Proteomic Tool Historic Market Size by Application (2018-2023)
3.2.2 Global Genomic and Proteomic Tool Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Genomic and Proteomic Tool Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Genomic and Proteomic Tool Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Genomic and Proteomic Tool Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Genomic and Proteomic Tool Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Genomic and Proteomic Tool Revenue Breakdown by Application (2018-2029)
4 Genomic and Proteomic Tool Competition Analysis by Players
4.1 Global Genomic and Proteomic Tool Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genomic and Proteomic Tool as of 2022)
4.3 Date of Key Players Enter into Genomic and Proteomic Tool Market
4.4 Global Top Players Genomic and Proteomic Tool Headquarters and Area Served
4.5 Key Players Genomic and Proteomic Tool Product Solution and Service
4.6 Competitive Status
4.6.1 Genomic and Proteomic Tool Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 3billion, Inc.
5.1.1 3billion, Inc. Profile
5.1.2 3billion, Inc. Main Business
5.1.3 3billion, Inc. Genomic and Proteomic Tool Products, Services and Solutions
5.1.4 3billion, Inc. Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.1.5 3billion, Inc. Recent Developments
5.2 Bio-Rad Laboratories, Inc.
5.2.1 Bio-Rad Laboratories, Inc. Profile
5.2.2 Bio-Rad Laboratories, Inc. Main Business
5.2.3 Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Products, Services and Solutions
5.2.4 Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.2.5 Bio-Rad Laboratories, Inc. Recent Developments
5.3 Lucigen Corp.
5.3.1 Lucigen Corp. Profile
5.3.2 Lucigen Corp. Main Business
5.3.3 Lucigen Corp. Genomic and Proteomic Tool Products, Services and Solutions
5.3.4 Lucigen Corp. Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.3.5 Macrogen, Inc. Recent Developments
5.4 Macrogen, Inc.
5.4.1 Macrogen, Inc. Profile
5.4.2 Macrogen, Inc. Main Business
5.4.3 Macrogen, Inc. Genomic and Proteomic Tool Products, Services and Solutions
5.4.4 Macrogen, Inc. Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.4.5 Macrogen, Inc. Recent Developments
5.5 Abbott
5.5.1 Abbott Profile
5.5.2 Abbott Main Business
5.5.3 Abbott Genomic and Proteomic Tool Products, Services and Solutions
5.5.4 Abbott Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.5.5 Abbott Recent Developments
5.6 Thermal Fisher Scientific, Inc.
5.6.1 Thermal Fisher Scientific, Inc. Profile
5.6.2 Thermal Fisher Scientific, Inc. Main Business
5.6.3 Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Products, Services and Solutions
5.6.4 Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.6.5 Thermal Fisher Scientific, Inc. Recent Developments
5.7 Bio-Synthesis, Inc.
5.7.1 Bio-Synthesis, Inc. Profile
5.7.2 Bio-Synthesis, Inc. Main Business
5.7.3 Bio-Synthesis, Inc. Genomic and Proteomic Tool Products, Services and Solutions
5.7.4 Bio-Synthesis, Inc. Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.7.5 Bio-Synthesis, Inc. Recent Developments
5.8 GE Healthcare
5.8.1 GE Healthcare Profile
5.8.2 GE Healthcare Main Business
5.8.3 GE Healthcare Genomic and Proteomic Tool Products, Services and Solutions
5.8.4 GE Healthcare Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.8.5 GE Healthcare Recent Developments
5.9 QIAGEN NV
5.9.1 QIAGEN NV Profile
5.9.2 QIAGEN NV Main Business
5.9.3 QIAGEN NV Genomic and Proteomic Tool Products, Services and Solutions
5.9.4 QIAGEN NV Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.9.5 QIAGEN NV Recent Developments
5.10 Novogene Corp.
5.10.1 Novogene Corp. Profile
5.10.2 Novogene Corp. Main Business
5.10.3 Novogene Corp. Genomic and Proteomic Tool Products, Services and Solutions
5.10.4 Novogene Corp. Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.10.5 Novogene Corp. Recent Developments
5.11 Waters Corp.
5.11.1 Waters Corp. Profile
5.11.2 Waters Corp. Main Business
5.11.3 Waters Corp. Genomic and Proteomic Tool Products, Services and Solutions
5.11.4 Waters Corp. Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.11.5 Waters Corp. Recent Developments
5.12 OriGene Technologies
5.12.1 OriGene Technologies Profile
5.12.2 OriGene Technologies Main Business
5.12.3 OriGene Technologies Genomic and Proteomic Tool Products, Services and Solutions
5.12.4 OriGene Technologies Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.12.5 OriGene Technologies Recent Developments
5.13 Takara Bio, Inc.
5.13.1 Takara Bio, Inc. Profile
5.13.2 Takara Bio, Inc. Main Business
5.13.3 Takara Bio, Inc. Genomic and Proteomic Tool Products, Services and Solutions
5.13.4 Takara Bio, Inc. Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.13.5 Takara Bio, Inc. Recent Developments
5.14 Vela Diagnostics
5.14.1 Vela Diagnostics Profile
5.14.2 Vela Diagnostics Main Business
5.14.3 Vela Diagnostics Genomic and Proteomic Tool Products, Services and Solutions
5.14.4 Vela Diagnostics Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.14.5 Vela Diagnostics Recent Developments
6 North America
6.1 North America Genomic and Proteomic Tool Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Genomic and Proteomic Tool Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Genomic and Proteomic Tool Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Genomic and Proteomic Tool Market Dynamics
11.1 Genomic and Proteomic Tool Industry Trends
11.2 Genomic and Proteomic Tool Market Drivers
11.3 Genomic and Proteomic Tool Market Challenges
11.4 Genomic and Proteomic Tool Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
